ema semaglutide naion june 2025 GLP-1 Drug Can Cause Rare, Potentially Blinding Side Effect, Warns EMA safety committee to review

Robust anti-obesity and metabolic effects of a dual GLP-1/Gcg receptor peptide agonist in rodents and non-human primates

This is high-value information that normally costs hundreds of dollars in a clinichere, you get it for free

Stimulation of the vagus nerve with ACH as neurotransmitter increases the force and frequency of gastric contraction, whereas stimulation of sympathetic nerves inhibits gastric motility through the release of norepinephrine

In fact, emerging evidence suggests potential benefits to their combined use: Enhanced Fat Oxidation : Preliminary studies hint that adequate vitamin C levels may facilitate more efficient fat oxidation, potentially amplifying L-carnitine's fat-burning effects

doi 10.1007/s40264-023-01392-3 109 BestWRBecktelJMSingletonJWKernF

Below we compare the different side effects for each medication, with similarities in bold